Authors

Nonfasting triglycerides and ischemic heart disease in men and women

Triglyceride levels are usually measured after the patient has fasted, and then exclude remnant lipoproteins. Except for the first few hours of the morning, individuals are usually in a nonfasting state for most of the day. We investigated whether nonfasting triglyceride levels predicted the risk of myocardial infarction (MI), ischemic heart disease, and death in the general population. Results showed that increased nonfasting triglyceride levels were associated with an increased risk of MI, ischemic heart disease, and death.

Repositioning GLP-1 Drugs for Neurologic Disease: Evidence, Advances, and Outlook

GLP-1 medications are revolutionizing treatment for neurological conditions.

Intermittent inotropic therapy: A clinician's opinion

Can any physician consider using intermittent inotropic therapy in patients with congestive heart failure?

The Nurse's Role in Recruitment and Retention of Clinical Trial Participants

Recruiting patients to participate in clinical trials is a challenging and time-consuming endeavor, especially when it comes to cancer clinical trials.

Lessons Learned from My Doctor-Patients

A doctor writes on his experiences in treating colleagues in his psychiatry practice, and the humility he's gained from it.

Case-Based Peer Perspectives in Fabry Disease

Dawn Laney, MS, CGC, CCRC, Assistant Professor and Director, Emory Genetic Clinical Trials Center, talks misdiagnosis in Fabry disease through a case study.

Those Who Online Bank, Online Shop

Brighten Your Cool Weekend Wear This Season

American Society of Hematology Meeting Highlights

The American Society of Hematology (ASH) held its 49th AnnualMeeting at the Georgia World Congress Center in Atlanta in December. The following reports provide summary coverage of meeting highlights,primarily focusing upon notable research breakthroughs relatingto hematological malignancies.

Daily Antituberculosis Therapy Superior for Pulmonary TB in PLWH

A daily, 6-month ATT regimen in HIV-positive patients with TB receiving concomitant ART proved superior to an intermittent regimen in terms of efficacy and prevention of ARR.